High Intensity Focused Ultrasound (HIFU) Market Analysis 2025–2033

High-Intensity Ultrasound Therapy Market Size and Forecast 2025-2033

Global High Intensity Ultrasound Therapy Market Overview

Global High-intensity focused Ultrasound (HIFU) therapy is a noninvasive medical treatment that uses focused ultrasound waves to target and treat specific tissues within the body. This advanced technique works by focusing high-frequency sound waves at a precise point, where they generate heat and cause controlled thermal ablation of the targeted tissue. HIFU can be used to treat most conditions, such as tumors, uterine fibroids, and some neurological disorders, destroying or shrinking the tissue to be treated without incision or surgery.

The main usage of HIFU is within oncology, as the treatment is used to address the localized tumor, particularly of organs such as the prostate, liver, and pancreas. It is also increasingly used to treat benign conditions such as uterine fibroids and breast tumors. Further potential uses of HIFU lie in dermatology to be used for rejuvenation of the face and for skin tightening by utilizing the non-invasive properties for stimulating collagen production. Being able to target tissues more precisely, minimize damage in the surrounding areas, and having reduced recovery time makes HIFU a promising alternative for surgical interventions.

Key Growth Drivers in the High-Intensity Ultrasound Therapy Market

Advances in Ultrasound Technology

Advancements in ultrasound technology and systems have significantly contributed to the growth of the market for high-intensity ultrasound therapy. Advances in real-time monitoring, precision in imaging, and improvements in terms of effectiveness and safety levels in HIFU treatments helped enhance the capabilities of those therapies. In this light, clinicians could more clearly identify tumors or affected areas with greater precision, not causing damage to healthy areas. Moreover, portable and low-cost ultrasound devices have become more accessible, thus making HIFU popular in many healthcare settings, even smaller hospitals and outpatient clinics. In October 2024, GE HealthCare introduced the new Versana Premier, the latest release in the Versana ultrasound family of reliable, affordable, easy-to-use, and versatile ultrasound systems.

Increasing Demand for Non-Invasive Treatment Alternatives

The high-intensity ultrasound therapy market is primarily driven by the growth in demand for non-invasive and minimally invasive treatments. Patients prefer alternatives to traditional surgical approaches, and with the less invasive treatment options like HIFU, they gain quicker recovery times, fewer complications, and no need for anesthesia. As HIFU can treat a range of conditions, from tumors and fibroids to those that do not involve cuts or stitches, it supports patient preferences for less invasive and more convenient healthcare options and drives its market growth forward. In Oct 2023, GE HealthCare reported that it had partnered with Novo Nordisk to drive further clinical and product development of peripheral-focused ultrasound's (PFUS). This new technology can potentially stimulate specific regulation of metabolic function in the human body through ultrasound and may favor the treatment of chronic conditions such as type 2 diabetes and obesity.

Increasing Number of Chronic Diseases and Cancers

The increasing population of chronic diseases, ranging from cancer, is immensely driving the demand for high intensity ultrasound therapy. With increasingly diagnosed cases of cancer worldwide, there is a growing urgency for non-invasive but practical treatments. High-intensity focused ultrasound therapy is gaining popularity as an emerging remedy for localized tumors, even when traditional surgery cannot be executed. Moreover, with improvements in patient outcomes and less side effect in healthcare systems, targeted destruction of tumors by the therapy with fewer risks and speed recovery supports the growing incorporation in oncology. In 2022, it was estimated that there were 20 million new cases of cancer worldwide and 9.7 million deaths due to cancer.

Market Challenges in the High Intensity Focused Ultrasound

High Cost of Equipment and Limited Accessibility

One of the main challenges the high-intensity ultrasound therapy market faces today is the equipment needed to carry out HIFU treatments. Advanced technology, specialized machines, and the costs of maintaining ultrasound systems are expensive, which can limit access to this therapy, especially in low-resource regions or smaller healthcare facilities. This will result in inequality in the availability of treatments since only well-funded hospitals or specialized centers can afford and implement such advanced therapies, which prevents their wide acceptance.

Lack of Skilled Professionals and Training

There are another major challenges in the high-intensity ultrasound therapy market such as need for more trained professionals who would be skilled in the handling of HIFU equipment and interpreting results. HIFU treatment requires precise targeting and real-time imaging, which necessitates high expertise. A dearth of adequately trained technicians and medical personnel may result in suboptimal treatment results or even complications. As the technology advances, there is a growing need for specialized training programs and educational initiatives to ensure that clinicians are proficient in using these advanced therapeutic devices safely and effectively.

United States High-Intensity Ultrasound Therapy Market

The high-intensity ultrasound therapy market in the United States is growing rapidly because of the advancements in medical technology and the increasing demand for non-invasive treatment options. There are thousands of specialized medical centers and hospitals in the United States where HIFU is applied to treat such diseases as prostate cancer, uterine fibroids, and other kinds of tumors. Increasing the demand for non-invasive interventions and awareness in health-related issues also helps increase adoption for HIFU treatments. Research and clinical trials underway further propel the market. The U.S. shall continue to remain a pace-setter in medical advancements. For example, the International Agency for Research on Cancer reports that in 2022, there were approximately 230,125 cases of prostate cancer in the country, and 33,746 deaths were reported. In November 2022, the National Cancer Institute (NCI), a U.S. Government agency for cancer research, launched a study on Prostate Cancer with radiation therapy. The study is in phase- 2 of clinical trials and will be completed by December 2028.

Germany High-Intensity Ultrasound Therapy Market

Germany is one of the leading countries in Europe for high-intensity ultrasound therapy, with several healthcare providers offering HIFU treatments for various medical conditions, including tumors and benign diseases. Established health care infrastructure within the country and emphasis of high technologies in medicine foster the environment for this market. A lot of encouragement of government research and development within the health care sector put Germany on track to continue extending the utilization of noninvasive therapies. HIFU is sure to be adopted into European regions more and more due to such scenarios. In June 2023, Exo collaborated with Sana Kliniken AG to bring its high-performance, handheld ultrasound platform, and artificial intelligence to more medical staff to enable real-time decisions that improve patient outcomes, streamline workflow inefficiencies, and lower costs.

China High-Intensity Ultrasound Therapy Market

The high-intensity ultrasound therapy market in China is growing rapidly. This is because the country has an increasing prevalence of chronic diseases such as cancer, and the healthcare system is expanding. As China continues to build its investment in advanced medical technologies, the use of HIFU therapy for cancers is becoming increasingly common in major metropolises like Beijing and Shanghai. With the intent of enhancing accessibility in healthcare provisions and increased spending on the health sector, the environment has become quite positive for revolutionary treatments such as high intensity ultrasound therapy. In February 2023 - GE Healthcare formed a long-term joint venture with a subsidiary of a Chinese state-owned pharmaceutical company to offer non-premium CT and general imaging ultrasound solutions.

Brazil High-Intensity Ultrasound Therapy Market

Brazil is emerging as a key market for high-intensity ultrasound therapy in South America, due to its advanced healthcare infrastructure and growing medical tourism sector. HIFU is becoming increasingly popular for treating localized cancers and other benign conditions in the country. The Brazilian government's efforts to enhance access to advanced medical technologies and therapies and the country's well-established network of healthcare professionals are expected to boost the demand for non-invasive treatments like HIFU in the region. In July 2024, Philips Foundation, with its mission to provide access to quality healthcare for 100 million people a year in underserved communities by 2030, and SAS Brasil announced the launch of an innovation lab dedicated to digital health education. The initiative focuses on improving healthcare in remote communities in Brazil.

Saudi Arabia High-Intensity Ultrasound Therapy Market

The high-intensity ultrasound therapy market in Saudi Arabia is growing as the country invests in advanced medical technologies and seeks to enhance its healthcare services. With a focus on noninvasive treatments and improving the quality of healthcare for its citizens, Saudi Arabia has increasingly adopted high-intensity ultrasound therapy for conditions such as cancer and uterine fibroids. The rapidly developing health infrastructure and the rising demand for advanced treatment in the Middle East country are likely to propel growth in the market. October 2023, Royal Philips, a global leader in health technology, is highlighting innovations in healthcare at the Global Health Exhibition.

Market Segmentation

Imaging Technology

• Ultrasound HIFU Therapy
• MRI HIFU Therapy

Application 

• Prostate Cancer
• Uterine Fibroids
• Neurological Disorders
• Aesthetics
• Others

End-User 

• Diagnostic Centers
• Hospitals
• Research Centers
• Others

Regional Insights

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia – Pacific

• China
• Japan
• India
• South Korea
• Thailand
• Malaysia
• Indonesia
• Australia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa

Rest of the World

All companies have been covered from 3 viewpoints:

•    Overview
•    Recent Development
•    Revenue

Company Analysis:

• Koninklijke Philips N.V.
• Johnson & Johnson
• Hitachi Ltd.
• General Electrics
• Medtronic Plc.
• Stryker
• EDAP TMS S.A,
• Theraclion

Report Details: